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Abstract
Innate immune cells like monocytes patrol the vasculature and mucosal surfaces, recognize
pathogens, rapidly redistribute to affected tissues and cause inflammation by secretion of
cytokines. We previously showed that monocytes are reduced in blood but accumulate in
the airways of patients with Puumala virus (PUUV) caused hemorrhagic fever with renal
syndrome (HFRS). However, the dynamics of monocyte infiltration to the kidneys during
HFRS, and its impact on disease severity are currently unknown. Here, we examined longi-
tudinal peripheral blood samples and renal biopsies from HFRS patients and performed in
vitro experiments to investigate the fate of monocytes during HFRS. During the early stages
of HFRS, circulating CD14–CD16+ nonclassical monocytes (NCMs) that patrol the vascula-
ture were reduced in most patients. Instead, CD14+CD16– classical (CMs) and CD14
+CD16+ intermediate monocytes (IMs) were increased in blood, in particular in HFRS
patients with more severe disease. Blood monocytes from patients with acute HFRS
expressed higher levels of HLA-DR, the endothelial adhesion marker CD62L and the che-
mokine receptors CCR7 and CCR2, as compared to convalescence, suggesting monocyte
activation and migration to peripheral tissues during acute HFRS. Supporting this hypothe-
sis, increased numbers of HLA-DR+, CD14+, CD16+ and CD68+ cells were observed in the
renal tissues of acute HFRS patients compared to controls. In vitro, blood CD16+ mono-
cytes upregulated CD62L after direct exposure to PUUV whereas CD16– monocytes upre-
gulated CCR7 after contact with PUUV-infected endothelial cells, suggesting differential
mechanisms of activation and response between monocyte subsets. Together, our findings
suggest that NCMs are reduced in blood, potentially via CD62L-mediated attachment to
endothelial cells and monocytes are recruited to the kidneys during HFRS. Monocyte
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mobilization, activation and functional impairment together may influence the severity of dis-
ease in acute PUUV-HFRS.
Author summary
Hantaviruses are re-emerging human pathogens that can cause severe disease, typically
manifesting in the lungs or kidneys. The virus preferentially infects the endothelial cells
without killing them. Therefore, the vascular leakage associated with hantavirus disease,
and hemorrhagic fever with renal syndrome (HFRS) is believed to be a consequence of the
dysregulated immune response to infection. In the present study, in a cohort of PUUV-
infected patients with acute HFRS, we describe a striking depletion of nonclassical mono-
cytes from circulation while classical and intermediate monocyte frequencies are increased.
Importantly, we found increased numbers of cells expressing monocyte and macrophage
markers in the kidneys of patients with HFRS. The monocytes remaining in circulation
show signs of activation, migration to the periphery and impairment in their ability to
respond to TLR stimulation. Interestingly, the magnitude of monocyte activation was asso-
ciated with greater disease severity. In addition, we also noted that different monocyte sub-
sets differ in how they recognize and respond to cell-free or cell-associated hantavirus
exposure. Collectively, our study greatly adds to what is currently known about how mono-
cytes behave during human hantavirus disease, and highlights the importance of studying
functional differences across the major monocyte subsets at greater resolution.
Introduction
Hantaviruses (genus Orthohantavirus, family Hantaviridae, Order Bunyavirales) are zoonotic
viruses that pose a clear burden to human health [1,2]. Hantaviruses enter the body primarily
via inhalation and infection is typically accompanied by viremia, which suggests that circula-
tion is a likely route of systemic dissemination for the virus [3]. The severity and symptoms of
the hantavirus-caused human diseases depend on the causative virus species. Hantaviruses of
Eurasia (i.e. “old world”) cause hemorrhagic fever with renal syndrome (HFRS) whereas han-
taviruses of the Americas (i.e. “new world”) can cause hantavirus pulmonary syndrome (HPS)
[1,4–6]. Although the most affected organ varies from kidneys in HFRS to lungs in HPS, a hall-
mark of both diseases is increased vascular leakage. Microvascular endothelial cells, that form
the barrier between the capillary bloodstream and tissues, are the prime target cells of hantavi-
rus infection in humans but the virus itself does not directly affect endothelial cell permeabil-
ity. Instead, vascular leakage is likely a consequence of an excessive immune response to
hantavirus infections [6–8], and several immune-related processes have been suggested to be
involved [9–11].
Monocytes are critical mediators of innate immune responses at mucosal surfaces and in
blood. In addition, monocytes can migrate to peripheral tissues. Monocytes interact closely
with endothelial cells during extravasation [12], which further increases the importance of
investigating monocytes in the context of hantavirus infection, known to affect endothelial cell
barrier functions. Three distinct monocyte subsets have been described based on their surface
expression of CD14 and CD16: CD14+CD16– classical monocytes (CM), CD14+CD16+ inter-
mediate monocytes (IM) and CD14–CD16+ nonclassical monocytes (NCM) [13]. CMs can
translocate from blood through the endothelium into tissues, and under inflammatory condi-
tions take on macrophage- or dendritic cells (DC)-like properties [13]. IMs are potent cytokine
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producers and expand in response to infections, sepsis and vaccinations [13,14]. NCMs, also
called patrolling monocytes since they “crawl” on the endothelium [15], are well-equipped to
sense danger signals such as virus infections [16].
Monocyte transmigration through the endothelium is dependent on interactions with
adhesion proteins, many of which are shared between several leukocytes and endothelial cells
[17]. During inflammatory conditions monocytes are captured from free-flowing blood by
endothelial P- and E-selectins or through monocyte L-selectin (CD62L) and endothelial CD34
interactions [18]. The initial capture is followed by firm monocyte arrest mediated through
interactions between monocyte integrins and EC-expressed intercellular adhesion molecule 1
(ICAM1) and vascular cell adhesion molecule 1 (VCAM1). Elevated levels of ICAM1 are
detected in HFRS patients [19,20] and in hantavirus-infected endothelial cells in vitro [9,21],
indicating that the virus-infected endothelium does have strong propensity to attract mono-
cytes during acute HFRS. The migration of monocytes to the site of infection is mediated by
soluble chemokines that interact with chemokine receptors expressed on the cell surface.
Monocytes egress from the bone marrow and infiltration into tissues is dependent on CCL2
and CCL3 interactions with CCR2 [22]. Monocytes can also migrate efficiently through CCR6,
similar to observations in macrophages in various disease models [23,24]. CCR7, on the other
hand, guides trafficking to the lymph nodes [25,26].
Here we describe an early reduction of circulating NCMs during severe acute HFRS. Con-
current increased hematopoietic progenitor frequencies in blood suggest their mobilization
from the bone marrow to replenish the reduced circulating NCM pool. Increased numbers of
HLA-DR+, CD14+, CD16+ and CD68+ cells in kidney tissues of acute HFRS indicated pro-
nounced monocyte extravasation from blood into tissues during HFRS. Monocyte kinetics
during HFRS, and expression of activation, adhesion and migration markers together suggest
a direct role for monocytes in kidney pathology during HFRS.
Results
Study design and patient characteristics
Longitudinal blood samples were obtained from 23 patients hospitalized due to PUUV-caused
HFRS during acute (5–10 days after symptom onset) and convalescence stages (11–30, 180
and 360 days after onset of symptoms) of the disease (Fig 1A and Table 1). Blood samples from
9 age- and sex-matched uninfected controls (UC) were also included. Thrombocyte counts,
creatinine values and mean arterial pressure (MAP) values were used to calculate adapted
sequential organ failure assessment (a-SOFA) scores, to stratify patients by HFRS disease
severity (Table 2). Thirteen out of 23 (57%) patients were current smokers. Severe thrombocy-
topenia (< 50 x 109/L) was found in 3 patients, severe acute kidney injury (AKI) (defined as
the highest plasma creatinine concentration >353.6 μmol/L [27]) in 8 patients. Three patients
were hypotensive with lowest measured MAP < 70 mmHg. Characteristic for HFRS, the
patients had significantly increased plasma levels of creatinine (Fig 1B) and C-reactive protein
(CRP) (Fig 1C) as well as decreased levels of blood thrombocytes (Fig 1D) during acute stage.
As expected [28], a majority (13 out of 17) patients with plasma samples available had detect-
able viremia during the acute phase of HFRS (Fig 1E).
Patients with more severe HFRS display delayed peak monocyte frequencies
We found that patients with severe disease as defined by a-SOFA score�5 had slightly elevated
total blood leukocyte counts compared to patients with mild disease (a-SOFA score <5)
(Fig 1F). Furthermore, the frequency of total monocytes was elevated during acute HFRS as
compared to UC but more pronounced in patients with a-SOFA scores�5 than in patients
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Fig 1. Viremic phase in Puumala virus-infected patients is characterized by thrombocytopenia, acute kidney injury and an overall increase in
monocyte frequencies. (A) Longitudinal peripheral blood samples (n = 102) were collected from 23 patients with serologically-confirmed acute
PUUV infection. Samples were obtained from the patients during acute infection (days 5–10) and convalescence (days 11–30, day 180 and day 360)
as well as from 9 uninfected controls (UCs). Levels of (B) creatinine (μmol/L in plasma), (C) C-reactive protein (CRP, mg/L in plasma), (D)
thrombocyte counts (109/L in blood) and (E) copy numbers of PUUV S segment in plasma (104/ml in plasma). Graphs show data from individual
subjects and lines indicate median values. Dotted lines indicate reference values in healthy adults. Each dot represents an individual sample and red
zone indicates reference range for thrombocyte counts in healthy adults (D). (F) Graph shows the total leukocyte counts (median ± interquartile
range, IQR) during PUUV infection for patients stratified by severity as lower, i.e. a-SOFA score<5 (empty circles) or higher, i.e. a-SOFA score�5
(filled circles). (G) Graph shows median ± IQR monocyte frequencies to total live cells (classical + intermediate + nonclassical monocytes) during
PUUV infection for patients stratified by severity as lower, i.e. a-SOFA score<5 (empty circles) or higher, i.e. a-SOFA score�5 (filled circles).
Dotted line represents median values from UCs. Statistical differences between day 360 and other time points (B-E), and patients with lower and
higher a-SOFA scores (F-G) were assessed using a generalized estimated equation (GEE) model in SPSS and differences were considered significant
at p<0.05 (��p<0.01, ���p<0.001 and ����p<0.0001).
https://doi.org/10.1371/journal.ppat.1009400.g001
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with a-SOFA scores<5 (Fig 1G), suggesting an expansion of leukocytes including monocytes
in patients with more severe disease. Interestingly, this coincided with elevated CD34+ progen-
itor frequencies in blood during acute severe HFRS compared to during convalescence (S1A,
S1B and S1C Fig). Taken together, these data suggest that both monocytes and their progeni-
tors are altered during HFRS compared to uninfected controls in a manner that correlates
with disease severity.
Acute PUUV-associated HFRS is characterized by a loss of nonclassical
monocytes from circulation
To further dissect the altered total blood monocyte frequencies, we analysed the prevalence of
CD14+CD16– classical monocytes, CMs (green); CD14+CD16+ intermediate monocytes, IMs
(red) and CD14–CD16+ nonclassical monocytes, NCMs (blue) (Figs 2A and S2A). During the
acute phase of HFRS, frequencies of CM and IMs increased compared to uninfected controls
(UCs), but returned to similar frequencies as in UCs during convalescence (Fig 2B and 2C). In
contrast, NCMs were significantly reduced in frequency during acute HFRS compared to con-
valescence (Fig 2D). In the DC compartment, no statistically significant fluctuations in fre-
quencies over course of disease was observed (S3 Fig). When we compared the monocyte
frequencies of patients stratified by a-SOFA scores, we observed that in the patients with
higher a-SOFA scores, peak frequencies of CMs and IMs were observed later as compared to
Table 1. Distribution of HFRS patient samples over time.
Days after symptom onset
























Total (n) 20 19 13 25 13 12
Acute phase (n = 52) Convalescent phase (n = 50)
https://doi.org/10.1371/journal.ppat.1009400.t001
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patients with lower a-SOFA scores (peak frequencies observed at 5–6 days after symptom
onset) (Fig 2E and 2F). Strikingly, we observed a pronounced drop in NCM frequencies in
both groups early in the acute phase, that remained low also during convalescence compared
to UCs (Fig 2G).
Monocytes are found in increased numbers in the kidneys of patients with
acute PUUV-HFRS
We stained a unique set of bouin-fixed paraffin-embedded kidney biopsies from 37 patients
with acute HFRS and 43 patients with other kidney diseases (controls) for HLA-DR, CD14,
CD16 and CD68 (Fig 3A–3D). The frequency of HLA-DR+, CD14+, CD16+ and CD68+ cells
were all significantly increased in patients with HFRS as compared to patients with other kid-
ney diseases (Fig 3E–3H). The cells, likely monocyte-derived macrophages, localized predomi-
nantly to tubulointerstitial space (Fig 3A–3D), consistent with the typical finding of



















P01 34 F Yes 4 70.5 9.8 96 67 70 2
P02 38 F Yes 8 109.1 9.6 55 91 79 5
P03 41 F Yes 4 15.9 8.9 156 68 87 2
P04 41 F Yes 4 30.5 9.5 106 63 85 2
P05 46 F No 6 66.9 11.5 23 240 68 6
P06 56 F No 8 25.5 6.9 118 297 98 5
P07 56 F Yes 4 30.5 9.2 83 78 89 3
P08 57 F Yes 11 101.1 9.7 124 491 66 8
P09 25 M No 4 22.8 9.8 139 878 85 5
P10 33 M Previous 7 15.9 7.4 212 679 91 7
P11 37 M Yes 5 55.3 14.8 38 384 84 6
P12 40 M Yes 8 32.8 12.2 43 1071 92 7
P13 42 M Yes 7 45.3 13.6 75 480 - 6
P14 43 M Yes 9 57.8 12.9 257 359 90 6
P15 48 M Previous 8 47.5 14.5 101 841 103 5
P16 51 M Yes 4 42.4 7.5 93 85 85 3
P17 52 M Yes 3 91.9 6.8 110 152 92 2
P18 52 M Previous 9 153.7 12.1 62 117 68 4
P19 54 M No 8 85.2 16.9 56 349 77 5
P20 55 M Previous 3 67 5.4 125 81 90 1
P21 63 M No 3 175.3 8.7 79 125 86 3
P22 64 M No 3 82.5 5.2 68 82 79 2
P23 65 M Yes 6 19.2 7.2 78 263 85 4
F = female, M = male. Acute phase laboratory results represent highest values for CRP, creatinine, leukocytes and lowest values for thrombocytes and mean arterial
pressure.
� Plasma C-reactive protein (CRP); reference <3 mg/L.
~ Leukocyte count; normal range 3.4–8.2 x109/L.
§ Thrombocyte count; normal range 150–360 x109/L.
¶ Plasma creatinine; reference <90 μmol/L for women, <100 μmol/L for men.
# Mean arterial pressure; reference 70–100 mmHg.
† Adapted-sequential organ failure assessment (a-SOFA) score; calculated from thrombocytes, creatinine and mean arterial pressure.
https://doi.org/10.1371/journal.ppat.1009400.t002
PLOS PATHOGENS Monocyte redistribution from blood to kidneys in hemorrhagic fever with renal syndrome
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009400 March 10, 2021 6 / 24
Fig 2. Sustained depletion of nonclassical monocytes in blood from patients with severe HFRS as compared to uninfected controls.
(A) Plots depict the monocyte subsets in a UC and a representative HFRS patient over the course of disease (day 6–360) (classical (CD14
+CD16−), intermediate (CD14+CD16+) and nonclassical (CD14−CD16+) monocytes). (B-D) Graphs show frequencies (to total live
cells) of (B) CMs (green), (C) IMs (red) and (D) NCMs (blue) in PBMCs from patients (filled bars) and HCs (empty bars). Circles
represent individual patients. Statistical differences between day 360 and other time points were assessed using a generalized estimated
equation (GEE) model in SPSS and differences were considered significant at p<0.05 (�p<0.05 and ��p<0.01). (E-G) Graphs show
median ± IQR frequencies of (E) CMs (green), (F) IMs (red) and (G) NCMs (blue) in PBMCs from patients stratified by severity as
lower, i.e. a-SOFA score<5 (empty circles) or higher, i.e. a-SOFA score�5 (filled circles). Median frequencies of respective monocyte
subset in UCs are indicated with dotted lines. Statistical differences between patients with lower and higher a-SOFA scores were assessed
using a generalized estimated equation (GEE) model in SPSS and differences were considered significant at p<0.05 (��p<0.01 and
���p<0.001).
https://doi.org/10.1371/journal.ppat.1009400.g002
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tubulointerstitial nephritis associated with acute HFRS (S2 Table). In addition, HLA-DR+ posi-
tive cells were found also in the glomeruli, which due to the absence of CD14, CD16 or CD68
most likely represented cells not from the monocyte lineage. The infiltration of monocytes and
monocyte-derived cells into the kidneys during HFRS may contribute to the renal pathology
observed during HFRS. We also noted that while the majority of monocytes detected in the
kidneys during HFRS were predominantly CD14+, the high frequencies of CD16+ could
explain the loss of NCMs from circulation. In addition, sustained mobilization of CD14+ CMs
to renal tissues during HFRS (as seen in the biopsies) may contribute to decreased differentia-
tion of CMs to IMs to NCMs in circulation.
Maturation and activation of monocytes during acute PUUV-HFRS
To understand whether alterations in monocyte frequencies were related to activation of the
cells during HFRS, we determined the cell surface expression of maturation, migration and
endothelial adhesion markers on the blood monocyte subsets (S2B Fig). All three monocyte
subsets displayed significantly increased HLA-DR during acute HFRS compared to UCs that
normalized during late convalescence (Fig 4A). The CD16-expressing IMs and NCMs signifi-
cantly upregulated CCR2 (Fig 4B) and CD62L (Fig 4C) expression during acute PUUV-HFRS,
as compared to late convalescence. And finally, CCR7 was upregulated on all three monocyte
subsets during acute disease (Fig 4D). Interestingly, we found significantly stronger upregula-
tion of CCR7 on CMs and IMs in patients with lower a-SOFA scores as opposed to those with
higher a-SOFA scores (Fig 4E–4G). We also noted that CCR2 was upregulated to a greater
extent by blood IMs in patients with higher a-SOFA scores (although statistically non-signifi-
cant; Fig 4H). As kidneys are affected during HFRS, we hypothesized that in response to
PUUV infection, monocytes may upregulate migration markers, infiltrate the kidneys and
contribute to the renal symptoms documented in HFRS patients.
Fig 3. Increased numbers of CD14+ and CD16+ cells are detected in kidneys during HFRS. (A-C) Representative
images of HRP-based kidney immunohistochemistry for (A) HLA-DR, (B) CD14 and (C) CD16 and (D) CD68 in
control (top panels) and acute HFRS patients (lower panels), both patients diagnosed with acute tubulointerstitial
nephritis. Hematoxylin was used as the counterstain. (E-H) Graphs show percentages of (E) HLA-DR (F) CD14 (G)
CD16 and (H) CD68 positive cells out of all cells in 43 non-HFRS controls and 37 acute HFRS kidney tissues as
assessed by automated computing methods. Statistical differences between groups were assessed by Mann-Whitney
test and considered significant at p<0.05. (���p<0.001 and ����p< 0.0001).
https://doi.org/10.1371/journal.ppat.1009400.g003
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Fig 4. Intermediate and nonclassical monocytes are more activated and express more endothelial adhesion and migration markers during acute HFRS. (A-D)
Graphs show median ± IQR MFI of (A) HLA-DR, (B) CCR2 (C) CD62L and (D) CCR7 surface expression on monocyte subsets (CM- green, IM-red and NCM- blue)
in PBMCs over the course of HFRS. Median MFI values from UCs are displayed as dotted lines for each monocyte subset. Statistical differences between day 360 and
other time points were assessed using a generalized estimated equation (GEE) model in SPSS and differences were considered significant at p<0.05 (�p<0.05, ��p<0.01,
PLOS PATHOGENS Monocyte redistribution from blood to kidneys in hemorrhagic fever with renal syndrome
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CD11c+ myeloid cells display impaired TNFα-production during acute
PUUV-HFRS
To determine whether HFRS also affected direct functional properties of blood monocytes, we
assayed the ability of CD11c+ myeloid cells to produce the key proinflammatory cytokines IL-
6 and TNFα with or without TLR7/8 stimulation. This required in vitro culture and stimula-
tion of the cells, which we optimized to 3 hours to minimize effects on cell surface proteins
used to identify cells of interest. Still, even 3 hours of culture resulted in downregulation of
CD16 [29], which prevented gating on separate monocyte subsets. Instead, we analysed the
cytokine response in total CD11c+ myeloid cells in the patient samples (S4A Fig). In the earli-
est acute phase of HFRS, a small proportion of the CD11c+ cells produced IL-6 without TLR
stimulation, which gradually disappeared over the course of disease (S4B and S4C Fig). Upon
TLR7/8L stimulation, 2–5% of the CD11c+ myeloid cells expressed IL-6 in both UC and acute
and convalescent patient samples but we did not observe significant differences in their
response to TLR stimulation (S4D Fig). IL-6 production in the absence of TLR stimulation
negatively correlated with thrombocytopenia, but only in patients with higher a-SOFA scores
(S4E Fig). In contrast to IL-6, the frequency of TNFα producing CD11c+ cells did not vary sig-
nificantly across the course of HFRS, or between patients and UCs (Fig 5A). However, we
observed a distinct impairment in the TNFα production from CD11c+ myeloid cells in
response to TLR7/8L stimulation, during the acute phase as compared to UCs as well as at day
360. Additionally, in patients with higher a-SOFA scores, the impairment in TNFα production
correlated with thrombocytopenia over the course of disease (Fig 5B). Taken together, these
���p<0.001 and ����p<0.0001). (E-H) Graphs show median ± IQR MFI of CCR7 expression on (E) CMs, (F) IMs and (G) NCMs; and (H) MFI of CCR2 expression on
IMs from patients stratified by severity as lower, i.e. a-SOFA score<5 (empty circles) or higher, i.e. a-SOFA score�5 (filled circles). Median frequencies of respective
monocyte subset in UCs are indicated with dotted lines. Statistical differences between patients with lower and higher a-SOFA scores were assessed using a generalized
estimated equation (GEE) model in SPSS and differences were considered significant at p<0.05 (�p<0.05 and ��p<0.01).
https://doi.org/10.1371/journal.ppat.1009400.g004
Fig 5. Myeloid cells from acute HFRS patients produce IL-6 but have impaired TNFα production in response to additional TLR stimulation. (A)
Graph displays median frequency ± IQR TNFα producing cells in CD11c+ myeloid cells in PBMCs in UCs (n = 3) and HFRS patients (n = 15) in the
absence (circle) or presence (square) of TLR 7/8L stimulation for 3h. Statistical differences between groups (of similar exposure conditions) were
assessed by mixed-effects analysis using Dunnett’s multiple correction test and considered significant at p< 0.05. (��p<0.01 and ���p<0.001). (B) Lines
display bivariate linear regression analysis between thrombocyte counts (109/L) and frequency of (C) IL-6 or (D) TNFα producing CD11c+ myeloid
cells without (left) or with (right) TLR 7/8L stimulation. The shaded area represents the 95% confidence region for the fitted line. Patients are stratified
by severity as lower, i.e. a-SOFA score<5 (blue) or higher, i.e. a-SOFA score�5 (pink). r represents Spearman ρ and statistical differences were
considered significant at p<0.05. UC = uninfected controls.
https://doi.org/10.1371/journal.ppat.1009400.g005
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data suggest not only an alteration in frequency but also in certain functional responses within
the myeloid immune cell compartment during HFRS.
Cytokine levels were elevated in plasma during acute PUUV-HFRS
The functional properties of monocytes are strongly influenced by cytokines and chemokines
present in the local environment. To obtain insights on the inflammatory and pro-migratory
milieu in peripheral blood during acute HFRS, we measured the levels of various cytokines
and chemokines in plasma samples that matched the analysed PBMC samples for patients and
time points. We measured the concentrations of the cytokines TNFα, IL-6, IL-18 IL-10, IL-1β,
IL-12p70, IFNα, IFNγ, M-CSF and GM-CSF; and the chemokines CCL2, CCL3 and CCL7. In
general, several cytokine levels (TNFα, IL-6, CCL2, IL-8, IL-10 and IL-18) were mildly elevated
during the acute phase (days 5–10) as compared to UCs, and declined to steady state levels in
convalescence (Fig 6A). Somewhat surprisingly, when split by a-SOFA severity score, there
was no consistent pattern in the plasma concentrations from patients with higher vs. lower
scores (Fig 6B–6E). The proinflammatory cytokines IL-6 (Fig 6B) and TNFα (Fig 6C), but also
the more immunoregulatory cytokine IL-10 (Fig 6D) were elevated in patients compared to
UCs. Mild cases displayed a second peak of these cytokines around day 9–10 which was not
seen in patients with severe disease. The chemokine CCL2 was only moderately upregulated
compared to UCs (Fig 6E). We observed a correlation between cytokine levels and thrombocy-
topenia (Fig 6F); and between cytokine levels and plasma creatinine levels (Fig 6G), both hall-
marks of acute PUUV-associated HFRS suggesting that, although not supported by a-SOFA
based patient stratification, cytokine production in patients may still contribute to HFRS dis-
ease. We also detected a significant increase in the levels of M-CSF in patients during acute
HFRS as compared to convalescent phase (Fig 6H) supporting the idea of active myelopoiesis
during acute HFRS.
CD16+ monocytes show more pronounced CD62L upregulation in
response to direct virus exposure in vitro
During acute PUUV-HFRS, monocytes in circulation are directly exposed to the virus as well
as to virus-infected endothelial cells. Since we observed increased expression of the endothelial
adhesion marker CD62L on CD16-expressing monocytes (IMs and NCMs) and CCR7 on all
monocyte subsets in patients with acute HFRS caused by PUUV, we investigated the conse-
quences of in vitro exposure to PUUV-Suonenjoki strain (shown to have wild-type properties
[30]) of bead-enriched CD16+ (IMs and NCMs) and CD16– (CMs) monocytes (Fig 7A).
Monocytes were either directly exposed to virus or added to a monolayer of PUUV-infected
blood microvascular endothelial cells (BECs). Both CD16+ and CD16– monocytes upregulated
CD62L after direct exposure to PUUV or TLR7/8L, but in both cases CD16+ monocytes dis-
played higher level of CD62L induction than CD16– monocytes (Fig 7B, top panel). This find-
ing suggests that CD16+ monocytes respond more strongly to hantaviruses than CD16–
monocytes, which is in line with previous studies showing the ability of NCMs to efficiently
sense viruses. Interestingly, after exposure to BECs, regardless of infection or TNF-α treat-
ment, both CD16+ and CD16– monocytes lost their CD62L expression, possible due to bind-
ing with CD34, the endothelial cell ligand for CD62L, and subsequent cleaving and/or
internalization.
CD16– monocytes consistently displayed higher CCR7 expression than CD16+ monocytes
after direct exposure to PUUV as well as after co-incubation with PUUV-infected BECs (Fig
7B middle panel). Strikingly, while direct exposure of CD16– or CD16+ monocytes to virus or
TLR7/8L did not have a clear impact on CCR7 expression, exposure to infected or TNFα
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Fig 6. Plasma levels of pro-inflammatory cytokines are elevated during HFRS infection. (A) Heatmap represents log10 cytokine concentrations
(as assayed by Luminex and ELISAs) in plasma for UCs (n = 5) and HFRS patients (n = 21) over the course of acute PUUV infection and during
convalescence. The color bar ranges from min (green) to max (red) within a column for each cytokine, yellow representing median values and
white boxes representing no cytokine detection, and grey represents no samples assayed. (B-D) Graphs show median ± IQR plasma concentrations
(pg/mL) of (B) IL-6, (C) TNFα, (D) IL-10 and (E) CCL2 in patients stratified by severity as lower, i.e. a-SOFA score<5 (empty circles) or higher,
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i.e. a-SOFA score�5 (filled circles). Median plasma cytokine concentration in UCs are indicated with dotted lines. (F-G) Lines display bivariate
linear regression analysis between log10 cytokine values of (F) TNFα, IL-6, IL-10 and CCL-2 against thrombocyte counts (10
9/L). (G) Lines of fit
display bivariate linear regression analysis between log10 cytokine values of TNFα and IL-6 against creatinine levels (μmol/L). The shaded area
represents the 95% confidence region for the fitted line. r represents squared Spearman ρ and statistical differences were considered significant at
p<0.05. UC = uninfected controls. (H) Graph shows median ± IQR plasma concentrations (pg/mL) of M-CSF over the course of HFRS in patients.
Statistical differences between day 360 and other time points were assessed using a generalized estimated equation (GEE) model in SPSS and
differences were considered significant at p<0.05 (�p<0.05 and ��p<0.01).
https://doi.org/10.1371/journal.ppat.1009400.g006
Fig 7. CD16+ and CD16– enriched monocytes respond differently during in vitro PUUV infection. (A) Peripheral blood monocytes were first
enriched by negative selection to remove B, T, NK cells and granulocytes using a RosetteSep enrichment kit. Plots show a representative sample of
enriched monocytes before (pre-isolation) and after (post-isolation) isolation using magnetic CD16+ beads. Post-isolation graphs show CD16– fraction
that is enriched in CD14+ CMs (green gate) and the CD16+ fraction that is enriched in CD16+ IMs and NCMs (violet gate). (B) Graphs show MFI of
CD62L (top panels), CCR7 (middle panels) and CD80 (lower panels) expression on CD16– (green) or CD16+ (violet) monocytes exposed to PUUV
(MOI = 1) directly for 1 h followed by 19 hr of incubation with fresh media (left panels) or PUUV-infected (MOI = 10, for 20 h) BECs (right panels);
n = 5 from two independent experiments. Statistical differences between CD16+ and CD16– monocytes were assessed by two-way ANOVA with
Tukey’s multiple comparisons test and considered significant at p< 0.05 (��p<0.01, ��� p<0.001 and ���p<0.0001). (C) Representative images of
HLA-DR staining of CD16+ (top panels) and CD16– (lower panels) monocytes adhered to endothelial cells (n = 7 donors). HLA-DR staining (green)
defines monocytes and endothelial cell nuclei are counterstained with Hoechst 3342 (blue). (D) Graph summarizes % adherence of CD16+ (violet) or
CD16– (green) monocyte adhesion to endothelial cells and lines connect data from same donors. Statistical differences were assessed by two-way
ANOVA with Tukey’s multiple comparisons test and considered significant at p<0.05.
https://doi.org/10.1371/journal.ppat.1009400.g007
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treated BECs upregulated CCR7 expression in both cell types, suggesting that activated endo-
thelial cells but not the virus itself are needed for monocyte CCR7 upregulation in vitro, and
perhaps in HFRS patients. We did not observe any significant differences in CD80 upregula-
tion between CD16– and CD16+ monocytes, except upon direct exposure to TLR7/8L (Fig 7B,
bottom panel). We also assessed the ability of CD16+ and CD16– monocytes to adhere to
PUUV-infected BECs by confocal imaging and quantification (Fig 7C). Both CD16+ and
CD16– monocytes displayed increased adhesion to PUUV-infected or TNFα-treated BECs
suggesting that PUUV infection elevates the adhesive properties of endothelial cells towards
monocytes (Fig 7D). This mechanism might explain the initial loss of monocyte subsets from
circulation during acute HFRS.
Discussion
HFRS and HPS are characterized by vascular leakage due to increased endothelial permeabil-
ity. Circulating monocytes, especially patrolling NCMs, are in constant interaction with the
endothelium and may play important roles in hantavirus pathogenesis. We report that the fre-
quencies of circulating NCMs significantly decreased whereas CMs and IMs increased during
the acute stage of HFRS. In line with this, we also observed increased monocyte infiltration
into kidney tissues of patients with acute HFRS. In addition to increased HLA-DR expression
on all monocyte subsets during acute HFRS, we observed significant upregulation of CD62L
during acute HFRS, suggesting increased adhesion to the endothelium and migration into
peripheral tissues. Patients with higher a-SOFA scores (indicative of severe disease), displayed
significantly different kinetics for monocyte frequencies in circulation, as well as migration
markers, than patients with lower scores. Increased endothelial adhesion and infiltration to the
kidneys may together explain the observed differences in blood monocyte frequencies and
may contribute to the renal pathology during acute HFRS.
In line with the current study, increased numbers of circulating CMs and IMs as well as
decreased NCMs have been observed for Hantaan virus (HTNV) caused HFRS [31]. However,
in contrast to the current study, the loss of NCMs during HTNV-caused HFRS associated with
favourable disease outcome whereas increased CMs and IMs positively correlated with higher
disease severity. Therefore, the frequency of the different monocyte subsets in circulation dur-
ing HFRS may also depend on the virus causing HFRS. Interestingly, the loss of NCMs associ-
ated with fatality in acute Ebola virus infection [32] implying that loss of monocytes from
circulation can strongly influence the pathogenesis and outcome of viral hemorrhagic fevers in
general. In our prior study of PUUV-caused HFRS, performed on patients sampled in North-
ern Sweden, we observed diminished absolute numbers of all monocyte and DCs subsets dur-
ing the acute stage of the disease [33]. The underlying cause of the different patterns of
monocyte and DC responses observed between our two studies on PUUV-caused HFRS
patients may stem from geographical differences. Altogether, the clinical severity of HFRS
caused by PUUV; the severity of AKI (plasma creatinine elevation), inflammation, thrombocy-
topenia and capillary leakage, may suggest that HFRS is more severe in the Finnish cohort as
compared to the previously-analysed Swedish cohort [33–35]. This disparity in disease severity
may be attributed to, differences in host genetic factors or distinct PUUV strains circulating in
Northern Sweden and Central Finland [36]. Certain HLA-B and HLA-DR haplotypes have
been associated with more severe disease following infection with old and new world hantavi-
ruses, and polymorphisms in the TNF, VE-cadherin, integrin and endothelial nitric oxide
synthase genes have been associated with increased risk of severe disease in HFRS [37–39].
Although highly speculative, the apparent increase in monocyte and DC frequencies towards
the Finnish PUUV strain as opposed to the one circulating in Northern Sweden could also be
PLOS PATHOGENS Monocyte redistribution from blood to kidneys in hemorrhagic fever with renal syndrome
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009400 March 10, 2021 14 / 24
attributed to the different strains. In any case, further work is needed to clarify potential differ-
ences in HFRS disease manifestation between the two geographical locations.
The patients analysed in this study exhibited some upregulation of cytokines (TNFα, IL-6,
IL-18 and IL-10) during the acute stage of the disease compared to uninfected controls, which
gradually diminished to normal levels during late convalescence. This is in line with the acute
inflammation previously described in non-fatal hantavirus infections [40,41]. As expected
[42], increased levels of the pro-inflammatory cytokine TNFα associated with both severity of
AKI (plasma creatinine elevation) and thrombocytopenia. Additionally, elevated levels of IL-
10 at early acute stage associated with milder disease, indicating a possible role for the broad
anti-inflammatory and immunoregulatory functions of IL-10 [43]. We observed an increased
frequency of IL-6 producing CD11c+ cells, which implies that myeloid cells contribute to
increased plasma IL-6 levels during acute HFRS. However, this was not the case for TNFα, for
which CD11c+ cells from the acute stage of the disease showed impaired expression levels
upon in vitro challenge by TLR7/8 ligand, suggesting dysregulation of the myeloid cell com-
partment due to continued immune challenge during acute HFRS. The CD11c+ cells, largely
CD14+ classical monocytes, stimulated in vitro with TLR7/8L for 3 hours, also displayed
downregulation of CD16. The brief duration of this experiment restricted our ability to study
the exact phenotype of these cells in greater detail as previously reported [44]. To understand
the differentiation capacity of the monocytes remaining in circulation, future in vitro studies
including trajectory analysis may provide additional insight. CCL2 levels in plasma were mod-
erately upregulated during acute HFRS, despite higher expression of its cognate receptor
CCR2 on IMs and NCMs in HFRS patients compared to UCs. In our previous study [33] we
observed downregulation of CCR2 by monocytes exposed to PUUV in vitro, which is in con-
trast to our observations in HFRS patients. The CMs we observed in circulation may not have
been exposed to the virus, whereas monocytes that did encounter the virus may have migrated
to the kidneys, as suggested by the kidney biopsy data. The disparity in observations between
ex vivo and in vitro studies may be aided by chemokine receptors being quite sensitive to cul-
ture conditions, and by different viral strains being investigated in the studies. CCL2 is a well-
documented chemoattractant for monocytes and promotes cell migration towards sites of
inflammation [45,46]. However, CCL2 also facilitates monocyte egress from the bone marrow
[22,47]. As suggested by increased frequencies of CMs, CD34+ hematopoietic progenitors as
well as elevated levels of CCL2 and M-CSF, it is likely that emergency myelopoiesis occurs in
the bone marrow of patients with acute HFRS to replenish the early loss in monocytes and
overall loss of NCMs. This may result in increased frequencies of circulating monocyte precur-
sors later during acute disease and subsequently, normalization of monocyte frequencies to
levels seen in UCs during the convalescent phase of HFRS, and merits further investigation in
future studies.
All the monocyte subsets exhibited significantly elevated cell surface expression of HLA-DR
during the acute stage of HFRS, particularly IMs, which is in line with their superior ability
among monocytes to evoke T cell responses [48]. Our findings also show increased levels of
CCR7 on all monocyte subsets during acute HFRS, which in the case of CMs and IMs associ-
ated with lower disease severity. CCR7 regulates trafficking of leukocytes to and within the
lymphatic system [49]. In CCR7-/- mouse models, circulating leukocytes are significantly
increased and elevated numbers of monocytes migrate into tissues where they can cause dam-
age [50,51]. This observation together with our previous findings suggest that in acute HFRS
patients with higher monocyte CCR7 levels, CCR7 may regulate monocyte migration to lymph
nodes instead of unchecked peripheral tissue infiltration and possibly, subsequent immune-
mediated damage. In addition, stronger CCR7-mediated homing to lymph nodes will likely
prime adaptive immune responses more efficiently, which may again contribute to the milder
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pathology observed. Conversely, patients with low CCR7 expression may have increased
monocyte migration to peripheral tissues rather than lymph nodes, contributing to the pathol-
ogy associated with HFRS, as suggested previously [52]. Since we found increased numbers of
monocytes and monocyte-derived cells in the kidneys during HFRS as compared to other kid-
ney diseases, monocyte extravasation to the kidneys from circulation during acute HFRS
could help explain the loss of NCMs from blood, and the presence of CD68-expressing macro-
phage-like cells suggests in situ monocyte differentiation into macrophages.
To identify the manner of monocyte subset activation during HFRS, blood CD16+ (IMs
and NCMs) and CD16– (CMs) monocytes were isolated and exposed directly to PUUV or to
PUUV-infected primary endothelial cells, evaluating CD62L and CCR7 expression in particu-
lar. When directly exposed to PUUV, stronger upregulation of CD62L was observed on IMs
and NCMs than on CMs, in line with our observations in patients. CD62L expression was lost
on all monocytes in contact with endothelial cells, suggesting adhesion-mediated changes in
monocyte CD62L expression. Upregulation of CCR7 by monocytes was only observed when
exposed to PUUV-infected endothelial cells but not when directly exposed to virus, and con-
sistently higher in CMs. Therefore, contact with infected endothelial cells may be required for
CCR7 upregulation on monocytes in acute HFRS, the magnitude positively correlating with
milder disease. It is unlikely that endothelial cells in patients with severe disease would be
more permissive to virus replication than in mild cases, and lead to greater monocyte activa-
tion. Rather, other factors including host genetics may play a role in the propensity of mono-
cytes to upregulate CCR7 in response to infected endothelial cells, although this is currently
only our speculation. All monocytes displayed increased adhesion to PUUV-infected and to
TNFα-treated endothelial cells suggesting a general increase in the adhesive properties of
endothelial cells towards monocytes during acute HFRS. This could lead to a transient loss of
monocytes from circulation, which are actively replenished by monocyte mobilization from
the bone marrow. However, to understand the mechanism by which monocytes adhere to an
infected endothelium in the context of PUUV infection, and whether they contribute to local
inflammation and/or vascular leakage upon infiltration to the kidneys, further systematic in
vitro studies are required.
Taken together our results suggest that during severe PUUV-caused HFRS, monocytes are
activated upon exposure to PUUV in blood, stimulating endothelial adhesion and subsequent
redistribution from circulation to the kidneys. Our data indicate that monocytes contribute to
HFRS pathogenesis and disease severity during acute PUUV infection.
Material and methods
Ethics statement and patient material
The study was approved by the Ethics Committee of Tampere University Hospital (Nos.
99256, R18808 and R04180). All subjects gave written informed consent in accordance with
the Declaration of Helsinki. The study consisted of peripheral blood mononuclear cells
(PBMC) and plasma samples from 23 patients treated for serologically confirmed acute PUUV
infection at the Tampere University Hospital, Finland, during 2002–2007. The samples were
collected on sequential days during hospitalization (5–10 days after symptom onset) and 1–3
times during recovery on 11–30, 31–50, 180 or 360 days after symptom onset. Prior to analysis
PBMC and plasma samples were stored in liquid nitrogen and -80˚C, respectively. Patients
were stratified as having either severe or mild HFRS by adapting the SOFA (sequential organ
failure assessment)-based scoring system where the maximum levels of plasma creatinine (4 =
> 440, 3 = 300–440, 2 = 171–299, 1 = 110–170 and 0 =< 110 μmol/l), minimum level of
thrombocytes (4 =< 20, 3 = 20–49, 2 = 50–99, 1 = 100–150 and 0 => 150 x 109/L) and a
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lowest mean arterial blood pressure measured during hospitalization (1 =< 70 and 0 =� 70
mmHg) were ranked. A total adapted-SOFA (a-SOFA) score of� 5 (12 patients) was consid-
ered as severe and< 5 (11 patients) as mild. Similar adapted scores have been used for HFRS
previously [53]. A set of 80 individual archival (from years 1978–1988) bouin-fixed paraffin-
embedded kidney biopsy specimens from patients with acute HFRS (n = 37, 7–17 days after
symptom onset) or other kidney diseases (n = 41) were also obtained (listed in S2 Table). The
Finnish national supervisory authority of health and welfare approved the study on kidney
biopsies (No. V/19454/2018)
Sample collection
Venous blood samples were collected from all patients (acute and convalescent phase samples)
and uninfected controls in the study in 6 vacutainers containing EDTA as an anticoagulant
and stored on ice. Blood samples were centrifuged at 800g for10 min in room temperature
(RT) and plasma was collected and frozen at -70˚C. The blood volume was reconstituted with
RPMI (HyClone). Histopaque was added to Accuspin tubes and centrifuged at 800g for 30sec
at RT. PBMCs were obtained by density-gradient centrifugation after centrifugation at 800g
for 20 min at RT (without brake and cryopreserved in RPMI + 20% inactivated fetal calf serum
(FCS) (Gibco) + 10% DMSO (Sigma) and stored in liquid nitrogen.
Flow cytometry
Phenotypic analysis was performed on PBMCs using panels containing Live/Dead Blue (Life
technologies), CD1c (AD5-8E7; Miltenyi), CD3 (SP34-2 and SK7; BD), CD10 (HI10a; Biole-
gend), CD11c (B-Ly6, BD), CD14 (M5E2, BD), CD16 (3GE, Biolegend), CD19 (HIB19; Biole-
gend), CD20 (L27, BD), CD34 (561, Biolegend), CD45RA (HI100, Biolegend), CD56 (HCD56,
BD), CD62L (SK11, BD), CD66abce (TET2, Miltenyi Biotec), CD80 (L307.4, BD), CD86
(2331; BD); CD123 (7G3; BD), CD133 (7, Biolegend), CD141 (AD5-14H12; Miltenyi), CD146
(P1H12; Biolegend), HLA-DR (TU36, Life technologies), CCR2 (K036C2, Biolegend), CCR4
(L291H4, Biolegend), CCR6 (11A9, BD) and CCR7 (150503, BD) (Panels summarized in S3
Table). Fixation was performed with 1% paraformaldehyde. Samples were acquired on an
LSRFortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star).
Stimulation with TLR ligands and intracellular cytokine analysis
PBMCs were stimulated with 1 ng/mL 3M-019 (TLR 7/8 agonist) (Invivogen) for 3 hours (h)
in R10 [RPMI-1640 (Sigma-Aldrich) medium supplemented with 10% FCS, 5mM L-gluta-
mine, 100U/mL each of penicillin and streptomycin (all Invitrogen)] and incubated at 37˚C/
5% CO2. Brefeldin A (Sigma-Aldrich) was added at 10 mg/mL, 30 minutes after TLR stimula-
tion. Cells were stained with surface antibodies as above, followed by fixation and permeabili-
zation using a staining buffer set (eBioscience). Intracellular cytokine staining was performed
using TNFα (Mab11, BD) & IL-6 (MQ2-13A5, Biolegend) antibodies. Samples were acquired
on an LSRFortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree
Star).
Cytokine and chemokine assays
Cytokines and chemokines in plasma (1:2 dilution) were measured using a custom-designed
12-plex Luminex assay (for TNFα, IL-6, IFNα, IFNγ, IL-8, IL-10, IL-18, CCL2, CCL3, CCL7,
IL-1β and IL-12p70) kit (R&D Systems) and analyzed on the Bio-Plex 200 instrument (Bio-
Rad). Exact values were interpolated from standard curves (5PL logistic regression) on built-in
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Bio-Plex Software (Bio-Rad). M-CSF and GM-CSF in plasma was measured by enzyme-linked
immunosorbent assay (ELISA) from Sigma and R&D Systems, respectively, according to man-
ufacturer’s instructions. Exact values were interpolated from standard curves (5PL logistic
regression) on GraphPad Prism version 9.0 (GraphPad Software).
Viruses
The PUUV-Suonenjoki (PUUV-Suo) strain was propagated in a bank vole renal epithelial cell
line (MyGlaRec.B from EVAg), grown in Dulbecco’s minimum essential medium-high glucose
(DMEM; Sigma Aldrich) supplemented with 10% inactivated FCS, 100 IU/ml Penicillin,
100 μg/ml Streptomycin, 2mM L-glutamine and a mix of non-essential amino acids (Sigma
Aldrich). Virus was purified from cell culture supernatants by ultracentrifugation through
30% sucrose cushion (SW28 rotor, 27,000 rpm, 50 min, +4˚C) and suspended to the corre-
sponding growth medium. The infectious titer of PUUV stocks were routinely ~106−107
focus-forming units (FFU)/ml. Where indicated, PUUV was inactivated using UV crosslinker
(300,000 μJ/cm2, Stratalinker, Stratagene). For mock infections, conditioned cell culture super-
natant without virus infection was prepared in the same fashion as for virus preparations.
In vitro monocyte activation assays
Total monocytes were enriched from buffy coats of donors obtained from the Finnish Red
Cross blood service with RosetteSep monocyte enrichment kit (STEMCELL Technologies).
After washing, CD16+ monocytes were isolated using CD16 magnetic beads (Miltenyi Biotech)
and the remaining CD16– cells (confirmed to primarily consist of CD14+ monocytes) were
used in parallel. For activation experiments, monocytes were suspended to 1 million cells per
ml R10 medium. For direct virus exposure experiments, 250,000 monocytes were incubated
with PUUV at multiplicity of infection (MOI) 1, or equal volumes of UV-inactivated PUUV or
mock preparations for 1 h at 37˚C. Cells were centrifuged (400g for 10 min at 4˚C), virus inoc-
ulum removed and suspended back to 1 million cells/ml in R10. 1 ng/mL 3M-019 (TLR 7/8L)
(Invivogen) was used as a positive control. After incubation for 19 hr at 37˚C, cells were
stained for multicolor flow cytometry as described above. To study monocyte interactions
with PUUV-infected endothelial cells, human primary dermal blood microvascular endothe-
lial cells (BECs), grown in endothelial basal medium (EBM-2) supplemented with SingleQuots
Kit (all from Lonza) and used at passages 7–10, were infected with PUUV at MOI of 10 or
equal volumes of UV-inactivated PUUV for 1 h at 37˚C. For negative and positive controls,
BECs were either left untreated or treated with 50 ng/ml TNFα (R&D systems), respectively.
72h post infection, cell supernatants were removed and cells were washed. Isolated naïve
monocytes were added to PUUV-infected or TNFα-treated BEC monolayers in a 2.5:1 cell
ratio (250 000 monocytes / 100,000 BECs), incubated for 20 hr at 37˚C, cells scraped with rub-
ber policeman, washed, strained and analysed by multicolor flow cytometry as described
above.
Confocal imaging
To visualize monocyte adhesion to PUUV-infected endothelial cells, BECs were infected or
TNFα-treated with PUUV as described above, in 96-well plates (ViewPlate-96 black, PerkinEl-
mer), at a density of 10,000 cells per well. After 72 h isolated naïve monocytes were added to
BEC monolayers in a 5:1 cell ratio (100 000 monocytes / 20 000 BECs) and incubated for 1 h at
37˚C. Cells were washed twice with PBS, fixed with 4% paraformaldehyde for 10min and
blocked/ permeabilized (3% BSA; 0.1% Triton-X100 in PBS) for 10min. Cells were incubated
with mouse monoclonal anti-human HLA-DR antibody (HI43, Immunotools) followed by
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secondary AlexaFluor488-conjugated anti-mouse secondary antibody (Thermo Scientific)
both for 1hr at room temperature. Cells were washed three times with PBS before imaging
with PerkinElmer Opera Phenix spinning disk confocal microscope using a 20x water-immer-
sion objective (NA 1.0). The analysis of the positive monocytes was conducted with the Har-
mony software (PerkinElmer) by using a supervised linear classifier. The analysis pipeline and
intensity, morphology and texture features used in the classification are listed in S1 Table.
Immunohistochemistry and quantification
Paraffin-embedded kidney biopsy specimens from acute HFRS and unrelated kidney diseases
as controls were stained with HLA-DR, CD14, CD16 and CD68 antibodies followed by poly-
mer-based horseradish peroxidase (HRP) chromogenic detection and hematoxylin counter-
stain. All stainings were performed based on standard procedures at Helsinki University
diagnostic laboratory HUSLAB. Digital images were obtained with Zeiss Axioscan slide scan-
ner and quantification of HLA-DR, CD14, CD16 and CD68 positive cells as compared to total
number of cells was performed using Aiforia v4.8 cloud platform (Aiforia Technologies Oy,
Helsinki, Finland). This platform uses image-based artificial intelligence (AI) with high-per-
formance cloud computing to discriminate between HRP-positive and -negative cells in indi-
vidual tissues. The AI training process included ~2500 iterations based on ~500 annotations of
manually selected positive and negative objects with visible nuclei.
Statistics
Data were analyzed using SPSS software v 25.0 (IBM Corp.), GraphPad Prism version 6.0
(GraphPad Software) and JMP, version 14.2. (SAS Institute Inc., Cary, NC, 1989–2019). Cell
frequencies and cell surface marker expression levels at various time points during acute and
convalescent stage HFRS were assessed by generalized estimating equations (GEE) assuming
gamma distribution with log link function for the outcome variable of interest and setting the
last convalescence time point (360 days) as the reference category (SPSS). Sequential Sidak’s
test was used to control for multiple comparisons. The predictive value of measured variables
in determining severe or mild HFRS was also assessed by GEE. In this case the model included
the main effects of time points and their interaction with the variable of interest. Only the earli-
est individual patient sample at each time point was included for GEE analysis. The working
correlation matrix for GEE analysis was set to unstructured. For comparisons in TLR-stimula-
tion experiments, mixed-effects analysis was performed using Dunnett’s multiple correction
test. Differences between groups in in vitro experiments were assessed using one-way ANOVA
with Kruskal-Wallis test, and Dunn’s test to correct for multiple comparisons. Bivariate and
multivariate linear regression analysis was performed using JMP, choosing Spearman’s rank
correlation coefficient for nonparametric analyses. Data were considered significant at
p<0.05.
Supporting information
S1 Fig. CD34+ progenitors are increased in acute HFRS patients. (A) Gating strategy for
identification of CD34+ progenitors from PBMCs by flow cytometry. (B) Flow plots depict
CD34+ progenitors in a representative uninfected control and an HFRS patient over time (day
9-day 360). (C) Graph summarizes the frequencies of CD34+ cells in UCs (n = 3) and HFRS
patients (n = 16). Statistical differences between day 180 (too few data points at day 360) and
other time points were assessed using a generalized estimated equation (GEE) model in SPSS
and differences were considered significant at p<0.05 (��p<0.01 and ����p<0.0001).
(TIF)
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S2 Fig. Gating strategy used for identification of monocytes and dendritic cells from
PBMCs. (A) From total cells, live cells were identified as single cells negative for the live/dead
marker. The lineage negative, HLA-DR+ cells were identified as cells expressing HLA-DR, but
not CD3, CD19, CD20, CD56 or CD66. Myeloid cells were identified as CD11c-expressing
cells and from the CD11c– population, CD123+ cells were identified as plasmacytoid dendritic
cells (PDCs). From the CD11c+ cells, monocyte subsets were identified as CD14+CD16– clas-
sical monocytes (CM), CD14+CD16+ intermediate monocytes (IM) and CD14–CD16+ non-
classical monocytes (NCM). Myeloid DC subsets (CD1c+ and CD141+ MDCs) were identified
from the CD14–CD16– cells. (B) Histograms show the relative expression of HLA-DR, CCR2,
CD62L and CCR7 in classical, intermediate and nonclassical monocytes of a single representa-
tive HFRS patient over time (day 8 to day 360).
(TIF)
S3 Fig. Depletion of myeloid dendritic cells in blood from patients during HFRS as com-
pared to uninfected controls. (A) Gating strategy for identification of dendritic cells (DCs)
from PBMCs by flow cytometry. Representative uninfected control (UC) sample showing gat-
ing on CD11c+ myeloid cells which were negative for CD14 and CD16 to identify CD1c+
(coral) and CD141+ (maroon) myeloid DC subsets. From the CD11c– cells, CD123+ plasma-
cytoid DCs (teal) were identified. (B) Plots depict the myeloid DC (MDC) populations in a UC
and a representative HFRS patient over the course of disease (day 6–360). (C-E) Graphs show
frequencies (to total live cells) of (C) CD141+ MDCs, (D) CD1c+ MDCs and (E) PDCs in
PBMCs from patients (filled bars) and HCs (empty bars). Statistical differences between day
360 and other time points were assessed using a generalized estimated equation (GEE) model
in SPSS and differences were considered significant at p<0.05. (F-H) Graphs show
median ± IQR frequencies of (F) CD141+ MDCs, (G) CD1c+ MDCs and (H) PDCs in PBMCs
from patients stratified by severity as lower a-SOFA score (<5, empty circles) or higher a-
SOFA score (�5, filled circles). Median frequencies of respective DC subset in UCs are indi-
cated with dotted lines.
(TIF)
S4 Fig. Gating strategy used for identifying TNFα and IL-6 producing myeloid cells with
or without TLR stimulation. (A) Flow plots depict TNFα-producing CD11c+ myeloid cells
(gated as shown in S1 Fig) in a representative uninfected control and an HFRS patient over
time (day 8-day 360), in the absence (top) or presence of TLR 7/8L stimulation (bottom) in
vitro for 3hr. (B) Flow plots depict IL-6-producing CD11c+ myeloid cells (gated as shown in
S1 Fig) in a representative uninfected control (UC) and an HFRS patient over time (day 8-day
360), in the absence of TLR 7/8L stimulation (bottom) in vitro for 3hr, and the frequencies are
summarized in (C). (D) Graph displays frequency of IL-6 producing cells in CD11c+ myeloid
cells in PBMCs in UCs (n = 3) and HFRS patients (n = 15) in the absence (circle) or presence
(square) of TLR 7/8L stimulation for 3 hr. Statistical differences between groups (of similar
exposure conditions) were assessed by mixed-effects analysis using Dunnett’s multiple correc-
tion test and considered significant at p< 0.05. (E) Lines display bivariate linear regression
analysis between thrombocyte counts (109/L) and frequency of IL-6 producing CD11c+ mye-
loid cell without (left) or with (right) TLR 7/8L stimulation. The shaded area represents the
95% confidence region for the fitted line. Patients are stratified by severity as lower, i.e. a-
SOFA score <5 (blue) or higher, i.e. a-SOFA score�5 (pink). ρ represents Spearman rand sta-
tistical differences were considered significant at p<0.05.
(TIF)
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S1 Table. Image analysis pipeline parameters for Harmony software.
(XLSX)
S2 Table. Clinical characteristics of patients with kidney biopsies.
(XLSX)
S3 Table. Flow cytometry panels.
(XLSX)
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Smed-Sörensen.
Validation: Sindhu Vangeti, Tomas Strandin, Sang Liu, Anne Räisänen-Sokolowski, Antti
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